Alector Inc
NASDAQ:ALEC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Alector Inc
NASDAQ:ALEC
|
US |
|
Formula One Group
NASDAQ:LLYVK
|
US |
|
Industrias Penoles SAB de CV
F:4FO
|
MX |
|
Encision Inc
OTC:ECIA
|
US |
|
BlockMint Technologies Inc
XTSX:BKMT
|
CA |
|
Formula One Group
NASDAQ:LLYVA
|
US |
|
Formula One Group
OTC:LLYVB
|
US |
|
Formula One Group
NASDAQ:FWONK
|
US |
|
Formula One Group
OTC:FWONB
|
US |
|
C
|
CME Group Inc
F:MX4A
|
US |
|
BNP Paribas SA
F:BNPH
|
FR |
Intrinsic Value
Is ALEC undervalued or overvalued?
See the intrinsic value estimate for Alector Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Alector Does
Alector Inc. is a clinical-stage biotechnology company working on medicines for brain diseases such as Alzheimer’s and frontotemporal dementia. Its idea is to use the body’s immune system, especially cells in the brain called microglia, to help clear harmful proteins and slow disease progression. The company does not sell approved drugs itself; it develops drug candidates and tests them in clinical trials.
- Headquarters
- United States of America US
- Employees
- 103
- IPO date
- Feb 7, 2019
Revenue & Expenses Breakdown
Alector Inc
Earnings Waterfall
Alector Inc
The intrinsic value for Alector Inc (ALEC) under the Base Case is hidden USD.
Compared with the current market price of 2.09 USD, the stock appears hidden.
